REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVEMENT OF CHRONIC SPONTANEOUS URTICARIA DISEASE ACTIVITY

Jacobs, J., Maurer, M., Gimenez-Arnau, A. et al. (5 more authors) (2023) REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVEMENT OF CHRONIC SPONTANEOUS URTICARIA DISEASE ACTIVITY. In: Annals of Allergy, Asthma & Immunology. 2023 Annual Scientific Meeting - American College of Allergy, Asthma & Immunology, 09-13 Nov 2023, Anaheim, USA. Elsevier , S34-S35.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Dates:
  • Published: 2023
  • Published (online): 9 November 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Oct 2024 15:33
Last Modified: 07 Oct 2024 15:33
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.anai.2023.08.113
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)